Webinar-Highly Potent API Drug Product Development and Manufacturing Using Micronization Technology
Summary:Small molecule drug developers continue to realize the strong therapeutic potential of highly potent active pharmaceutical ingredients (HPAPIs), particularly in areas such as oncology. With this demand comes a critical need for safe manufacturing and containment technologies to produce high quality products. Micronization is a proven and widely used technology to address bioavailability and manufacturability challenges facing highly potent oral drugs. Development of HPAPIs presents unique challenges for product containment and requires special consideration in equipment selection, operating procedures and safety processes. This webinar will discuss how to classify HPAPIs in early development and share recommendations for safe product handling, from clinical manufacturing to commercialization. The speaker will also share the key advantages of using micronization technology for the development and manufacture of HPAPIs.